The USA spinal interbody fusion market size was valued at US$772.661 million in 2020 and is projected to grow at a CAGR of 4.04% during the forecast period to reach US$1,019.760 million by 2027.
According to NCBI internationally and within The United States, there are considerable variations in spinal surgery. Despite similar incidence and prevalence rates of spine problems in other nations, The United States has the highest rates of spine surgery in the world. There is little or no medical, clinical, or surgical data to back up such a wide range of outcomes.
Spinal interbody fusion is a surgical procedure in which two or more tiny bones of the spine are permanently fused to form a single, solid bone that eliminates motion between them. Spinal surgeries can be classified based on the spine area or the type of implant used. Plates, pedicle screw/rod fixation systems, and interbody devices are among the devices available. In recent years compared to any other spine surgeries, cervical fixation, thoracolumbar fixation, and interbody fusion procedures were shown to be the most regularly performed.
Invasive and minimally invasive spinal operations account for most spinal interbody fusions performed. While patients are increasingly choosing minimally invasive procedures to shorten recovery times and lower the risk of complications, a considerable number still require traditional surgical procedures.
According to NCBI (National Centre for Biotechnology Information), a vast number of developments in spinal interbody fusion surgery have occurred in the last 50 years. Despite this, spine surgeons have a long history of creativity, ingenuity, and resourcefulness to alleviate human misery caused by spinal deformity.
Surgical robots are becoming more widely used in the spine surgery market, with many hospitals now offering robot surgery for spinal disorders. Companies are focusing on developing surgical robots for spinal interbody fusion surgeries, along with implants and navigation tools. This has cleared the way for many other strategic collaborations between hospitals, spinal interbody fusion manufacturers, and robots manufacturers for linking the technologies and supporting new product releases, all of which are projected to propel the spinal interbody fusion industry for the forecasted period.
The growing popularity of minimally invasive surgery (MIS) is expected to drive up the market for spinal interbody fusion devices. Surgeons choose MIS over open surgery for various reasons, including less pain, a shorter recovery time, and less tissue damage. Minimally invasive procedures are being used to treat a wide spectrum of bone problems, according to Mini-invasive Surgery in 2020. According to NCBI (National Centre for Biotechnology Information) in the United States, around 400,000 spinal interbody fusion procedures are performed each year, making it one of the most prevalent and well-established treatment choices for spine trauma, degenerative conditions, and structural anomalies.
It is anticipated that the high cost of setup and the high cost of spinal interbody fusion surgeries coupled with an increase in medical tourism to Mexico and Japan for quality surgery services at lower cost will hamper the growth of the US spinal interbody fusion market during the forecast period.
An interbody fusion is a surgical type of spinal interbody fusion that includes removing the intervertebral disc from the disc space. Post this, surgeons usually implant metal, plastic, or bone spaces between 2 adjoining vertebrae. This helps in bone healing.
A hospital can perform both inpatient and outpatient surgeries. The difference between the two is where the patient stays post the surgery.
An outpatient surgery, also known as same-day or ambulatory surgery, occurs when a patient is scheduled to go home after the surgery on the same day. Outpatient surgery is becoming increasingly available due to advances in sedation, pain control, and surgical techniques. However, in post-Inpatient Surgery, patients are requested to stay at the hospital for at least one night post the procedure to avoid complications.
The United States of America has predicted to have a notable prevalence in the spinal interbody fusion devices market in the forecast period. The growing elderly population in the region provides robust scope for the market to grow. In the geriatric population, which is around 16.63% of the overall population of the USA according to the World Bank, the rise in spinal disorders and the rise in sports injuries and fatal accidents are all predicted to drive up demand for spinal interbody fusion devices in the USA. Furthermore, the region's well-established healthcare infrastructure is expected to drive market expansion. Furthermore, key player expansions are projected to enhance market growth by creating substantial untapped opportunities.
The COVID-19 epidemic has an impact on almost every business. The healthcare industries have been completely impacted so has the market for spinal interbody fusion devices. The COVID-19 epidemic situation in several nations has created certain obstacles for spinal interbody fusion devices, which are used in hospitals and clinics to provide orthopaedics services. One of the problems preventing clinics and hospitals from providing spine fusion services is the enormous strain on hospitals to provide services to COVID-19 patients.
|Market size value in 2020||US$772.661 million|
|Market size value in 2027||US$1,019.760 million|
|Growth Rate||CAGR of 4.04% from 2020 to 2027|
|Forecast Unit (Value)||USD Million|
|Segments covered||Type, Location, And States|
|Regions covered||California, Texas, New York, Others|
|Companies covered||Alphatec Spine, Inc., Globus Medical, Inc., Orthofix Medical Inc., Zimmer Biomet, NuVasive, Inc.|
|Customization scope||Free report customization with purchase|
Key Market Segments
1.1. Market Definition
1.2. Market Segmentation
2. RESEARCH METHODOLOGY
2.1. Research Data
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. The threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. US SPINAL INTERBODY FUSION MARKET BY TYPE
5.2. Anterior Lumbar Interbody Fusion
5.3. Lateral Lumbar Interbody Fusion
5.4. Oblique Lateral Interbody Fusion
6. US SPINAL INTERBODY FUSION MARKET BY LOCATION
7. US SPINAL INTERBODY FUSION MARKET BY STATES
7.4. New York
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Emerging Players and Market Lucrativeness
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Vendor Competitiveness Matrix
9. COMPANY PROFILES
9.1. Alphatec Spine, Inc.
9.2. Globus Medical, Inc.
9.3. Orthofix Medical Inc.
9.4. Zimmer Biomet
9.5. NuVasive, Inc.
*List is not exhaustive
Alphatec Spine, Inc.
Globus Medical, Inc.
*List is not exhaustive
All our studies come with 2 months of analyst support.
We are in compliance with the global privacy laws.